325 related articles for article (PubMed ID: 24490161)
1. Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.
Gómez-Gómez Y; Organista-Nava J; Gariglio P
Biomed Res Int; 2013; 2013():407052. PubMed ID: 24490161
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.
Sammarco ML; Tamburro M; Pulliero A; Izzotti A; Ripabelli G
Microrna; 2020; 9(3):174-186. PubMed ID: 31738147
[TBL] [Abstract][Full Text] [Related]
3. microRNAs are biomarkers of oncogenic human papillomavirus infections.
Wang X; Wang HK; Li Y; Hafner M; Banerjee NS; Tang S; Briskin D; Meyers C; Chow LT; Xie X; Tuschl T; Zheng ZM
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4262-7. PubMed ID: 24591631
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
5. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (Review).
González-Quintana V; Palma-Berré L; Campos-Parra AD; López-Urrutia E; Peralta-Zaragoza O; Vazquez-Romo R; Pérez-Plasencia C
Oncol Rep; 2016 Jan; 35(1):3-12. PubMed ID: 26530778
[TBL] [Abstract][Full Text] [Related]
7. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
9. The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17β-estradiol.
Gómez-Gómez Y; Organista-Nava J; Ocadiz-Delgado R; García-Villa E; Leyva-Vazquez MA; Illades-Aguiar B; Lambert PF; García-Carrancá A; Gariglio P
Int J Oncol; 2016 Aug; 49(2):549-58. PubMed ID: 27278606
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
Xin X; Jia-Yin Y; Jun-Yang H; Rui W; Xiong-Ri K; Long-Rui D; Liu J; Jue-Yu Z
Comput Biol Med; 2023 Jun; 159():106943. PubMed ID: 37099974
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in cervical cancer: evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance.
Pedroza-Torres A; López-Urrutia E; García-Castillo V; Jacobo-Herrera N; Herrera LA; Peralta-Zaragoza O; López-Camarillo C; De Leon DC; Fernández-Retana J; Cerna-Cortés JF; Pérez-Plasencia C
Molecules; 2014 May; 19(5):6263-81. PubMed ID: 24840898
[TBL] [Abstract][Full Text] [Related]
12. The role of miRNAs in the invasion and metastasis of cervical cancer.
Wang JY; Chen LJ
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833362
[TBL] [Abstract][Full Text] [Related]
13. Potential role of microRNAs in the treatment and diagnosis of cervical cancer.
Shen S; Zhang S; Liu P; Wang J; Du H
Cancer Genet; 2020 Oct; 248-249():25-30. PubMed ID: 32987255
[TBL] [Abstract][Full Text] [Related]
14. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.
Martinez I; Gardiner AS; Board KF; Monzon FA; Edwards RP; Khan SA
Oncogene; 2008 Apr; 27(18):2575-82. PubMed ID: 17998940
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
18. Deregulated miRNAs in human cervical cancer: functional importance and potential clinical use.
Li J; Liu Q; Clark LH; Qiu H; Bae-Jump VL; Zhou C
Future Oncol; 2017 Apr; 13(8):743-753. PubMed ID: 27806630
[TBL] [Abstract][Full Text] [Related]
19. [The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].
Zhu YK; Cheng N; Hu Y; Cen YZ
Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):251-6. PubMed ID: 23189617
[TBL] [Abstract][Full Text] [Related]
20. Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes.
Lin L; Cai Q; Zhang X; Zhang H; Zhong Y; Xu C; Li Y
Protein Cell; 2015 Aug; 6(8):575-588. PubMed ID: 25913515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
